Gene analysis of prostate tumor tissue, profiling by real-time rt-pcr of 46 genes
Medicare pricing data for 1 providers across 1 states
This is a specialized procedure with relatively few Medicare claims. Pricing data may be less reliable due to smaller sample sizes. Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis of prostate tumor tissue, profiling by real-time rt-pcr of 46 genes (HCPCS code 81541) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $3,777, but hospitals typically charge $3,900 — a 1.0x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $3,777, your out-of-pocket cost would be approximately $755.37. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.0x more than what Medicare allows for this procedure. Medicare actually pays $3,777 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Utah | $3,777 | $3,900 | 1 | 8,626 | 0.0% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber